Cite
HARVARD Citation
Jensen, A. et al. (2016). Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation?. Radiation oncology. 11 (1), pp. 1-9. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Jensen, A. et al. (2016). Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation?. Radiation oncology. 11 (1), pp. 1-9. [Online].